Jitendra Singh, Minister of Status of Science and Technology of the Union, officially launched the HPV test kits indigenous developed for the cervical cancer exam in a high profile event in Delhi on Thursday. The launch marks the culmination of the National Program entitled “Validation of the Indigenous Human Papilloma Virus (HPV) for the Cervical Cancer Singing in India”, a strategic initiative backed by GCI-Birac-DBT.
As part of the program, two HPV test kits developed by MyLab Discovery Solutions and Molbio Diagnostics were validated through multicenter clinical studies carried out among the main research institutions in India. The initiative aims to create profitable, precise and accessible diagnostic solutions adapted to the public health needs of India.
Among the validated kits, the MYLAB HR HR HR HR HR HR DNA test, designed to run on its automated compact platform, allows a precise and high -performance detection that can be climbed through medical care settings, included. The kit stood out for its integration of automation and ease of use in a decentralized environment.
Cervical cancer remains the second most common cancer among Indian women, and India represents one of the highest world burns. The availability of validated and indigenous indigenous test solutions is an important milestone to improve early detection and prevention strategies.
The HPV diagnostic test kit based on RTPCR based on MyLab sacrifices rapid care testing capabilities, critically for deployment in various medical care environments, partly in unattended areas are lacquered.
The test kits produced nationwide are expected to be deployed through national medical care programs, and officials suggest that this could fundamentally transform the detection and management of cervical cancer in the country. The successful development and validation of these kits also repeat a great step forward for the health self -sufficiency initiatives of India.
===
Posted on April 25, 2025